A Novel Mechanism for Th17 Inflammation in Human Type 2 Diabetes Mellitus
- PMID: 31767267
- DOI: 10.1016/j.tem.2019.11.002
A Novel Mechanism for Th17 Inflammation in Human Type 2 Diabetes Mellitus
Abstract
In their recent study, Nicholas et al. challenge the current dogma that T cell inflammation must be fueled by glycolysis and demonstrate a novel metabolic mechanism for Th17 inflammation in human type 2 diabetes mellitus (T2DM): a combination of increased environmental long-chain fatty acid metabolites coupled with decreased fatty acid oxidation.
Keywords: Th17; fatty acid oxidation; metabolism; obesity; type 2 diabetes.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Comment on
-
The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus.Biomed Pharmacother. 2018 May;101:287-292. doi: 10.1016/j.biopha.2018.02.103. Epub 2018 Feb 27. Biomed Pharmacother. 2018. PMID: 29499402 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical